Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 2
Treatment-assignment count: 0
Stratification count: 0
Manual Review Required
MSI-H / dMMR
NSCLC · Immune Checkpoint Inhibitor
MSI-H / dMMR is flagged as manual review required because public trials show inclusion required evidence in 9 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 10
Common snippets: MSI-H | MSI-H | MSI-H
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Low
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT03948763 | https://clinicaltrials.gov/study/NCT04521075 | https://clinicaltrials.gov/study/NCT03836352 | https://clinicaltrials.gov/study/NCT04114136 | https://clinicaltrials.gov/study/NCT03656718 | https://clinicaltrials.gov/study/NCT06047379 | https://clinicaltrials.gov/study/NCT03589339 | https://clinicaltrials.gov/study/NCT03767348 | https://clinicaltrials.gov/study/NCT02856425